Jane Street Group, LLC Pacira Bio Sciences, Inc. Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$11.7 - $28.46 $959,399 - $2.33 Million	82,000 New	82,000 $1.23 Million
Q1 2022 May 17, 2022	SELL	$60.03 - $76.49 $36,018 - $45,894	-600 Reduced 13.04%	4,000 $305,000
Q4 2021 Feb 15, 2022	SELL	$47.97 - $62.21 $1.03 Million - $1.33 Million	-21,400 Reduced 82.31%	4,600 $277,000
Q3 2021 Nov 16, 2021	BUY	$54.64 - $61.3 $1.15 Million - $1.29 Million	21,100 Added 430.61%	26,000 $1.46 Million
Q1 2021 May 18, 2021	SELL	$59.31 - $78.82 $907,443 - $1.21 Million	-15,300 Reduced 75.74%	4,900 $343,000
Q4 2020 Feb 17, 2021	BUY	$50.47 - $66.26 $393,666 - $516,828	7,800 Added 62.9%	20,200 $1.21 Million
Q2 2020 Aug 17, 2020	SELL	$30.8 - $52.47 $662,200 - $1.13 Million	-21,500 Reduced 63.42%	12,400 $651,000
Q2 2018 Aug 15, 2018	BUY	$27.5 - $39.8 $932,250 - $1.35 Million	33,900 New	33,900 $1.09 Million

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.